Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A Systematic Review of the Burden of Pancreatic Cancer in Europe: Real-World Impact on Survival, Quality of Life and Costs
Alfredo Carrato, Alfredo Falcone, Michel Ducreux, et al.
Journal of Gastrointestinal Cancer (2015) Vol. 46, Iss. 3, pp. 201-211
Open Access | Times Cited: 237

Showing 1-25 of 237 citing articles:

Epidemiology of Pancreatic Cancer: Global Trends, Etiology and Risk Factors
Prashanth Rawla, Tagore Sunkara, Vinaya Gaduputi
World Journal of Oncology (2019) Vol. 10, Iss. 1, pp. 10-27
Open Access | Times Cited: 1923
Epidemiology of pancreatic cancer
Milena Ilić, Irena Ilić
World Journal of Gastroenterology (2016) Vol. 22, Iss. 44, pp. 9694-9694
Open Access | Times Cited: 1179
NAPOLI-1 phase 3 study of liposomal irinotecan in metastatic pancreatic cancer: Final overall survival analysis and characteristics of long-term survivors
Andrea Wang‐Gillam, Richard Hubner, Jens T. Siveke, et al.
European Journal of Cancer (2019) Vol. 108, pp. 78-87
Open Access | Times Cited: 249
KRAS, TP53, CDKN2A, SMAD4, BRCA1, and BRCA2 Mutations in Pancreatic Cancer
Jonas Cicenas, Kotryna Kvederavičiūtė, Ingrida Meskinyte, et al.
Cancers (2017) Vol. 9, Iss. 5, pp. 42-42
Open Access | Times Cited: 236
Pancreatic cancer incidence trends: evidence from the Surveillance, Epidemiology and End Results (SEER) population-based data
Vanessa Gordon-Dseagu, Susan S. Devesa, Michael Goggins, et al.
International Journal of Epidemiology (2017) Vol. 47, Iss. 2, pp. 427-439
Open Access | Times Cited: 175
3D Bioprinted cancer models: Revolutionizing personalized cancer therapy
Robin Augustine, Sumama Nuthana Kalva, Rashid Ahmad, et al.
Translational Oncology (2021) Vol. 14, Iss. 4, pp. 101015-101015
Open Access | Times Cited: 134
Environmental cadmium exposure and pancreatic cancer: Evidence from case control, animal and in vitro studies
Vladimir Djordjević, David R. Wallace, Amie Schweitzer, et al.
Environment International (2019) Vol. 128, pp. 353-361
Open Access | Times Cited: 133
Green synthesis of gold nanoparticles from Scutellaria barbata and its anticancer activity in pancreatic cancer cell (PANC‐1)
Lei Wang, Jianwei Xu, Ye Yan, et al.
Artificial Cells Nanomedicine and Biotechnology (2019) Vol. 47, Iss. 1, pp. 1617-1627
Open Access | Times Cited: 124
Burden of pancreatic cancer along with attributable risk factors in Europe between 1990 and 2019, and projections until 2039
Jingru Yu, Xiaorong Yang, Wei He, et al.
International Journal of Cancer (2021) Vol. 149, Iss. 5, pp. 993-1001
Open Access | Times Cited: 99
Association of the location of pancreatic ductal adenocarcinoma (head, body, tail) with tumor stage, treatment, and survival: a population-based analysis
Felice N. van Erning, Tara M. Mackay, Lydia G. van der Geest, et al.
Acta Oncologica (2018) Vol. 57, Iss. 12, pp. 1655-1662
Open Access | Times Cited: 95
The Hippo Signaling Pathway in Pancreatic Cancer
Daniel Ansari, Henrik Ohlsson, Carl Althini, et al.
Anticancer Research (2019) Vol. 39, Iss. 7, pp. 3317-3321
Open Access | Times Cited: 86
Neoadjuvant therapy for pancreatic cancer
Jean Gugenheim, Anna Crovetto, Niccolò Petrucciani
Updates in Surgery (2021) Vol. 74, Iss. 1, pp. 35-42
Open Access | Times Cited: 60
Optimizing First-Line Chemotherapy in Metastatic Pancreatic Cancer: Efficacy of FOLFIRINOX versus Nab-Paclitaxel Plus Gemcitabine
Francesco Di Costanzo, Federica Di Costanzo, Lorenzo Antonuzzo, et al.
Cancers (2023) Vol. 15, Iss. 2, pp. 416-416
Open Access | Times Cited: 23
Current and projected incidence rates of pancreatic cancer in 43 countries: an analysis of the Cancer Incidence in Five Continents database
Songting Shou, Rui Liu, Jie He, et al.
BMJ Open Gastroenterology (2025) Vol. 12, Iss. 1, pp. e001544-e001544
Open Access | Times Cited: 1
Proteomics profiling of research models for studying pancreatic ductal adenocarcinoma
Mathilde Resell, Hanne-Line Rabben, Animesh Sharma, et al.
Scientific Data (2025) Vol. 12, Iss. 1
Open Access | Times Cited: 1
Anxiety, depression and quality of life in people with pancreatic cancer and their carers
Monika Janda, Rachel Ε. Neale, Kerenaftali Klein, et al.
Pancreatology (2017) Vol. 17, Iss. 2, pp. 321-327
Open Access | Times Cited: 87
Current therapeutic strategies for advanced pancreatic cancer: A review for clinicians
Rosella Spadi
World Journal of Clinical Oncology (2016) Vol. 7, Iss. 1, pp. 27-27
Open Access | Times Cited: 81
Randomised, open-label, phase II study of gemcitabine with and without IMM-101 for advanced pancreatic cancer
Angus Dalgleish, Justin Stebbing, Douglas JA Adamson, et al.
British Journal of Cancer (2016) Vol. 115, Iss. 7, pp. 789-796
Open Access | Times Cited: 70
Liposomal Irinotecan: A Review in Metastatic Pancreatic Adenocarcinoma
Yvette N. Lamb, Lesley J. Scott
Drugs (2017) Vol. 77, Iss. 7, pp. 785-792
Closed Access | Times Cited: 69
The Role of TRP Channels in the Metastatic Cascade
Benedikt Fels, Etmar Bulk, Zoltán Pethő, et al.
Pharmaceuticals (2018) Vol. 11, Iss. 2, pp. 48-48
Open Access | Times Cited: 66
Consensus statement on mandatory measurements in pancreatic cancer trials (COMM-PACT) for systemic treatment of unresectable disease
Emil ter Veer, L. Bengt van Rijssen, Marc G. Besselink, et al.
The Lancet Oncology (2018) Vol. 19, Iss. 3, pp. e151-e160
Open Access | Times Cited: 63
Characterising the impact of body composition change during neoadjuvant chemotherapy for pancreatic cancer
Oonagh Griffin, Sinead N. Duggan, Ronan Ryan, et al.
Pancreatology (2019) Vol. 19, Iss. 6, pp. 850-857
Closed Access | Times Cited: 59
Pancreatitis, Pancreatic Cancer, and Their Metabolic Sequelae: Projected Burden to 2050
Jaelim Cho, Maxim S. Petrov
Clinical and Translational Gastroenterology (2020) Vol. 11, Iss. 11, pp. e00251-e00251
Open Access | Times Cited: 56
A systematic literature review of health consumer attitudes towards secondary use and sharing of health administrative and clinical trial data: a focus on privacy, trust, and transparency
Elizabeth Hutchings, Max Loomes, Phyllis Butow, et al.
Systematic Reviews (2020) Vol. 9, Iss. 1
Open Access | Times Cited: 51
Can we screen for pancreatic cancer? Identifying a sub-population of patients at high risk of subsequent diagnosis using machine learning techniques applied to primary care data
Ananya Malhotra, Bernard Rachet, Audrey Bonaventure, et al.
PLoS ONE (2021) Vol. 16, Iss. 6, pp. e0251876-e0251876
Open Access | Times Cited: 43
Page 1 - Next Page

Scroll to top